(R)-4-(4-((4'-氯-4,4-二甲基-3,4,5,6-四氢-[1,1'-联苯]-2-基)甲基)哌嗪-1-基)-N-((4-((4-吗啉-1-(苯硫基)丁烷-2-基)氨基)-3-((三氟甲基)磺酰)苯基)磺酰)苯甲酰胺
Navitoclax (Synonyms: ABT-263; A-855071)
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
5 mg 10 mg
Product Availability
In-stock
Price
$118.00
Member price
Product Availability
In-stock
Price
$188.00
Member price
Quantity
- +
Product Overview
Product Name Navitoclax (Synonyms: ABT-263; A-855071)
CAS923564-51-6
FormulaC47H55ClF3N5O6S3
MW974.61
AppearanceWhite to light yellow powder
Storage conditionDry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).
Security information
Product details

Navitoclax, also known as ABT-263, is an orally bioavailable, synthetic small-molecule antagonist of a subset of the B-cell leukemia 2 (Bcl-2) family of proteins with potential antineoplastic activity. ABT-263 selectively binds to apoptosis suppressor proteins Bcl-2, Bcl-XL, and Bcl-w and prevents their binding to the apoptotic effectors Bax and Bak proteins, which may trigger apoptosis in tumor cells overexpressing Bcl-2, Bcl-XL, and Bcl-w.
Tags: buy Navitoclax (ABT-263) | purchase Navitoclax (ABT-263) | Navitoclax (ABT-263) cost | order Navitoclax (ABT-263) | Navitoclax (ABT-263) chemical structure | Navitoclax (ABT-263) in vivo | Navitoclax (ABT-263) in vitro | Navitoclax (ABT-263) formula | Navitoclax (ABT-263) molecular weight

Related literature
Related
Sorry, no related items
History
Navitoclax (Synonyms: ABT-263; A-855071)
Exendin-3 (9-39) amide/Avexitide
Darbufelone | CI-1004